Cho-Reyes Soojin, Celli Bartolome R, Dembek Carole, Yeh Karen, Navaie Maryam
Advance Health Solutions, LLC, New York, New York.
Harvard Medical School, Boston, Massachusetts and Chronic Obstructive Pulmonary Disease Center, Brigham and Women's Hospital, Boston, Massachusetts.
Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):267-280. doi: 10.15326/jcopdf.6.3.2018.0168.
Metered dose inhalers (MDIs) are commonly prescribed for inhalation therapy, but correct use is critical to promoting effective medication delivery. This systematic literature review and meta-analysis evaluates the overall and step-by-step prevalence of errors among adults with obstructive lung diseases in the United States who used MDIs.
Electronic and manual searches conducted between 1979-2018 using PubMed, EMBASE, PsycINFO, Cochrane, and Google identified 10 articles that met the following inclusion criteria: (a) English language, (b) U.S. adults diagnosed with chronic obstructive pulmonary disease, and (c) MDI use error rates. Meta-analytic techniques using random-effects models were applied to calculate effect sizes, weighted proportions, and 95% confidence intervals (CIs). Heterogeneity was assessed by the I statistic.
Aggregate findings revealed that 86.7% of patients (n=390, 95% CI 77.5-96.0) made at least 1 inhalation technique error, and 76.9% (n=885, 95% CI 65.8-87.9) incorrectly performed ≥ 20% of device use steps. The most prevalent step-by-step errors across the studies (n=1105) were failure to: (a) exhale fully and away from the inhaler before inhalation (65.5% [95% CI 52.0, 78.9]); (b) hold breath for 5-10 seconds (41.9% [95% CI 29.8, 53.9]); (c) inhale slowly and deeply (39.4% [95% CI 26.2, 52.5]); (d) exhale after inhalation (35.9% [95% CI 17.0, 54.8]); and (e) shake the inhaler before use (34.2% [95% CI 30.6, 37.7]).
Across the studies used in this meta-analysis more than three-fourths of U.S. adults with obstructive lung diseases used MDIs incorrectly. Our findings suggest the need for ongoing patient education and consideration of alternative devices to mitigate errors.
定量吸入器(MDIs)常用于吸入治疗,但正确使用对于促进有效给药至关重要。本系统文献综述和荟萃分析评估了美国患有阻塞性肺病的成年人使用MDIs时错误的总体及分步发生率。
1979年至2018年间,通过使用PubMed、EMBASE、PsycINFO、Cochrane和谷歌进行电子和手动检索,确定了10篇符合以下纳入标准的文章:(a)英文;(b)被诊断患有慢性阻塞性肺病的美国成年人;(c)MDIs使用错误率。采用随机效应模型的荟萃分析技术来计算效应量、加权比例和95%置信区间(CIs)。通过I统计量评估异质性。
汇总结果显示,86.7%的患者(n = 390,95% CI 77.5 - 96.0)至少犯了1个吸入技术错误,76.9%(n = 885,95% CI 65.8 - 87.9)错误地执行了≥20%的设备使用步骤。各项研究(n = 1105)中最常见的分步错误为:(a)吸入前未完全呼气且远离吸入器(65.5% [95% CI 52.0, 78.9]);(b)屏气5 - 10秒(41.9% [95% CI 29.8, 53.9]);(c)缓慢而深地吸气(39.4% [95% CI 26.2, 52.5]);(d)吸入后呼气(35.9% [95% CI 17.0, 54.8]);以及(e)使用前摇晃吸入器(34.2% [95% CI 30.6, 37.7])。
在本荟萃分析所使用的各项研究中,超过四分之三患有阻塞性肺病的美国成年人错误地使用了MDIs。我们的研究结果表明需要持续开展患者教育并考虑使用替代设备以减少错误。